| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4031020 | Ophthalmology | 2006 | 14 Pages |
Abstract
Repeated intravitreal injections of ranibizumab had a good safety profile and were associated with improved VA and decreased leakage from choroidal neovascularization in subjects with neovascular AMD.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jeffrey S. MD, Andrew N. MD, Peter Reed MD, Steven R. MD, Philip J. MD, PhD, Thomas A. MD, Richard F. MD, Ronald C. MD, Judy P. PhD, Gary PhD, Naveed MD, PhD,